Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

Clinical trial NCT05289167 · RECRUITING

Trial details

NCT number: NCT05289167
Sponsor: Northwell Health
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Graft-versus-host Disease

Start date: 2022-03-13
Primary completion: 2026-08-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.